Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Non‑drug, non‑invasive treatments given before heart surgery to protect the brain

Official title: Non-pharmacologial, Non-invassive Intervention Before Cardiac Surgry: a Randomized Controlled Trial

Run by China National Center for Cardiovascular Diseases · NCT06791551 · Data updated 2026-11-12

This trial will test whether remote ischemic preconditioning (RIPC) and transcranial electrical stimulation (tDCS) given before elective heart surgery can reduce stroke, delirium, and other brain complications in adults at high risk.

More Cardiac Surgery trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment200 (estimated)
SponsorChina National Center for Cardiovascular Diseases
Government
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJune 10, 2025
Main results expectedJuly 31, 2028
Study endsJuly 31, 2028
Registry record updatedJune 6, 2025
Trial IDNCT06791551 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–80 years old scheduled for elective cardiac surgery who are judged high-risk for postoperative neurological complications (for example, prior stroke or moderate-to-severe stenosis of head/neck arteries) and who can give informed consent.

Probably not a fit

People having emergency surgery, those outside the age range, low-risk surgical patients, or those unable to consent or comply with the protocol are unlikely to benefit from this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized controlled trial, adults aged 18–80 who are scheduled for elective cardiac surgery and identified as high risk for postoperative neurological complications will be assigned to receive active remote ischemic preconditioning and transcranial electrical stimulation or a sham/no-treatment control before surgery. Researchers will monitor for perioperative neurological outcomes such as stroke, delirium, and cognitive decline, and will collect safety data on the two non‑invasive interventions. The interventions are non‑pharmacological and applied prior to the operative period, with follow-up during the immediate postoperative phase. Results will compare rates of neurological complications and adverse events between the groups.

Why it matters

Potential benefit: If successful, these non-drug, non-invasive procedures could lower the risk of stroke, delirium, and other brain complications after cardiac surgery.

How similar studies have gone: Previous trials of remote ischemic preconditioning in cardiac surgery have produced mixed results, and use of transcranial electrical stimulation for perioperative brain protection remains relatively novel with limited clinical evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age range: 18-80 years old;
2. Surgical patients with heart disease;
3. Elective surgery;
4. Patients identified as high-risk for postoperative neurological complications; Previous stroke history; Moderate to severe stenosis of the head and neck arteries was evaluated;
5. Be able to understand and comply with the requirements of clinical trial protocols, and voluntarily sign informed consent forms.

Exclusion Criteria:

\-

Where it's running

  • Department of Neurology, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing,
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.